Fiche publication


Date publication

septembre 2022

Journal

Gynecologie, obstetrique, fertilite & senologie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr RAMANAH Rajeev


Tous les auteurs :
Briet M, Barkatz J, Frontczak S, Ramanah R, Buffet NC, Cristofari S

Résumé

Transgender patients are at increased risk of cancer, sexually transmitted diseases, short- and long-term postoperative complications in patients with vaginoplasty, but also unwanted pregnancy in non-hysterectomized trans men. However, access to care is often difficult for these patients, who often do not benefit from appropriate gynecological monitoring, especially for fear of judgment or discrimination. In view of the health risks of these patients, it is essential to be able to offer them specific and adapted gynecological follow-up. To date, there are no clear recommendations regarding the gynecological follow-up of transgender patients. We relied on the recommendations of the World Professional Association of Transgender Health (W-PATH) and the Endocrine Society Guideline and performed a literature review. We carried out several searches via pubmed in order to explore one by one the different aspects of gynecological follow-up, in particular of non-hysterectomized transgender men and transgender women with a vaginoplasty. It emerges from this a lack of follow-up of transgender people, with a reluctance to consult a gynecologist, associated with the lack of knowledge and experience of health professionals. Due to the risks identical to those of the general population, added to those specific to transgender people, it is important to be able to offer these patients specialized and personalized gynecological follow-up, and to raise awareness and train health professionals on the importance of and the specificities of the gynecological follow-up of these patients.

Mots clés

contraception, fertility preservation, neoplasms, néoplasies, préservation de fertilité, transgender, transgenre, transidentity, transidentité

Référence

Gynecol Obstet Fertil Senol. 2022 09 20;: